Cargando…
境外授权许可引进抗肿瘤新药临床研发策略的审评考虑
With the boom of China's innovative pharmaceutical industry, licensing-in model has gradually become an important research and development model for innovative pharmaceutical companies. The in-licensed drugs at different stages need different research and development (R & D) strategy in Chi...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346151/ https://www.ncbi.nlm.nih.gov/pubmed/35899440 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.27 |